Dae Hwa Pharm Co (XKRX:067080) Liabilities-to-Assets : 0.66 (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Dae Hwa Pharm Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩144,622 Mil. Dae Hwa Pharm Co's Total Assets for the quarter that ended in Mar. 2024 was ₩219,185 Mil. Therefore, Dae Hwa Pharm Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 0.66.

Dae Hwa Pharm Co Liabilities-to-Assets Historical Data

The historical data trend for Dae Hwa Pharm Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Liabilities-to-Assets Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Liabilities-to-Assets

Get a 7-Day Free Trial

0.49

0.51

0.53

0.59

0.65

Dae Hwa Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Liabilities-to-Assets	Get a 7-Day Free Trial															0.61	0.62	0.64	0.65	0.66

Competitive Comparison of Dae Hwa Pharm Co's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Dae Hwa Pharm Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dae Hwa Pharm Co's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dae Hwa Pharm Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Dae Hwa Pharm Co's Liabilities-to-Assets falls into.

Dae Hwa Pharm Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Dae Hwa Pharm Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )	=	Total Liabilities	/	Total Assets
	=	141809.467	/	219162.617
	=	0.65

Dae Hwa Pharm Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as

Liabilities-to-Assets (Q: Mar. 2024 )	=	Total Liabilities	/	Total Assets
	=	144622.15	/	219185.455
	=	0.66

Dae Hwa Pharm Co (XKRX:067080) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Dae Hwa Pharm Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co (XKRX:067080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Liabilities-to-Assets

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines